Recombinant Yersinia pestis Elongation factor G (fusA), partial

What is the role of Elongation factor G in Y. pestis protein synthesis?

Elongation factor G (fusA) in Y. pestis serves as a critical component in bacterial protein synthesis, specifically during the translocation phase of ribosomal activity. It functions as a GTPase that catalyzes the movement of tRNAs and mRNA through the ribosome after peptide bond formation, allowing for the continuation of protein elongation. This process requires GTP hydrolysis to provide the energy necessary for translocation.

In the context of Y. pestis pathogenesis, efficient protein synthesis is essential for rapid bacterial replication during infection and for the production of virulence factors. While Y. pestis genomes have been noted to contain two copies of elongation factor Tu (EF-Tu) , research on the specific characteristics of Y. pestis fusA remains an area requiring further investigation. The highly conserved nature of elongation factors across bacterial species suggests that fusA plays a similarly critical role in Y. pestis as in other bacteria.

How does Y. pestis fusA gene structure compare to other bacterial species?

The fusA gene structure typically includes domains responsible for:

• GTP binding and hydrolysis (G domain)

• Ribosome interaction

• Conformational changes necessary for translocation activity

Comparative analysis between Y. pestis fusA and that of other bacterial species reveals conservation of these functional domains, though species-specific variations may exist that could relate to the organism's particular environmental adaptations. These variations might be particularly relevant considering Y. pestis must adapt to both mammalian hosts and flea vectors during its lifecycle.

What structural characteristics are important for recombinant Y. pestis fusA functionality?

The structural integrity of recombinant Y. pestis fusA is paramount for its functionality in experimental settings. Like other bacterial elongation factors G, Y. pestis fusA likely possesses a multi-domain architecture consisting of five domains (I-V) with specific functions:

• Domain I (G domain): Contains GTP-binding motifs and is responsible for GTPase activity

• Domain II: Contributes to ribosome binding

• Domain III: Involved in conformational changes during translocation

• Domains IV and V: Mimic tRNA structure during the translocation process

To assess structural characteristics of purified recombinant fusA, researchers can employ circular dichroism spectroscopy, similar to methods used for studying the F1 antigen of Y. pestis where "circular dichroism [was used] to monitor the reassociation of monomeric rF1 into a multimeric form" . This technique provides valuable insights into secondary structure composition and conformational changes under varying conditions.

Maintaining proper domain organization and interdomain flexibility is crucial for fusA function, as the protein undergoes significant conformational changes during its catalytic cycle. Properly folded recombinant fusA should exhibit characteristic GTPase activity when stimulated by ribosomes, serving as a functional verification of structural integrity.

What expression systems are optimal for recombinant Y. pestis fusA production?

Several expression systems have proven effective for producing recombinant bacterial elongation factors, with specific considerations for Y. pestis fusA:

E. coli-based expression systems:

• BL21(DE3) strains with pET vector systems under T7 promoter control typically yield good expression levels

• Codon optimization for E. coli may be necessary to improve expression efficiency

• Lower induction temperatures (16-20°C) often improve solubility of recombinant fusA

• Fusion tags such as His6, GST, or MBP can enhance solubility and facilitate purification

Expression optimization table:

When designing expression constructs, researchers should consider including a cleavable tag to facilitate downstream purification while allowing removal of the tag for functional studies. For Y. pestis proteins, similar approaches to those used for recombinant F1 antigen production may be applicable, where successful expression and purification yielded functionally active protein .

What purification strategies yield the highest purity of recombinant Y. pestis fusA?

A multi-step purification strategy is recommended to achieve high purity recombinant Y. pestis fusA suitable for structural and functional studies:

• Initial capture: Affinity chromatography based on the fusion tag (e.g., Ni-NTA for His-tagged proteins)

• Intermediate purification: Ion exchange chromatography to separate fusA from proteins with different charge characteristics

• Polishing step: Size exclusion chromatography for final purification and to analyze oligomeric state

This approach parallels successful strategies used for other Y. pestis proteins, such as the recombinant F1 antigen, which was "purified by ammonium sulfate fractionation followed by FPLC Superose gel filtration chromatography" . For fusA specifically, gel filtration chromatography is particularly valuable as it allows assessment of proper oligomeric state and separation from aggregates or degradation products.

Typical purification profile:

The final purified product should be characterized by SDS-PAGE, Western blotting, and mass spectrometry to confirm identity and purity. Activity assays, including GTPase activity measurement, should be performed to verify functional integrity.

How can researchers verify the structural integrity of purified recombinant fusA?

Verification of structural integrity for purified recombinant Y. pestis fusA should employ multiple complementary approaches:

• Biophysical characterization:

  • SDS-PAGE and native PAGE to assess purity and oligomeric state

  • Dynamic light scattering to evaluate homogeneity and detect aggregation

  • Circular dichroism spectroscopy to analyze secondary structure content

• Functional verification:

  • GTPase activity assays (measuring phosphate release from GTP)

  • Ribosome binding assays to confirm interaction capabilities

  • In vitro translation assays to demonstrate functionality in protein synthesis

• Thermal stability assessment:

  • Differential scanning fluorimetry to determine melting temperature

  • Thermal denaturation monitored by circular dichroism

Similar approaches have proven valuable for other Y. pestis proteins, as demonstrated in studies of the F1 antigen where "using FPLC gel filtration chromatography and capillary electrophoresis, [researchers] have demonstrated that rF1 antigen exists as a multimer of high molecular mass" . For fusA, proper folding would be indicated by characteristic GTPase activity and ability to interact with ribosomes.

Researchers should establish baseline parameters for properly folded fusA by comparison with well-characterized bacterial elongation factors G from related species, providing benchmarks for evaluating their recombinant preparations.

What techniques are most effective for studying fusA protein-protein interactions in Y. pestis?

Investigating the interaction network of Y. pestis fusA requires sophisticated techniques that can capture both stable and transient interactions relevant to translation:

• Co-immunoprecipitation and pull-down assays:

  • Using tagged recombinant fusA to identify interacting partners from Y. pestis lysates

  • Analysis by mass spectrometry for identification of co-precipitated proteins

• Surface Plasmon Resonance (SPR) and Bio-Layer Interferometry (BLI):

  • Real-time binding kinetics between fusA and ribosomal components

  • Determination of binding constants (KD) for various interaction partners

  • Comparison of wild-type versus mutant fusA binding properties

• Cryo-electron microscopy (cryo-EM):

  • Visualization of fusA-ribosome complexes in different functional states

  • Structural insights at near-atomic resolution

  • Conformational analysis during the translocation cycle

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

  • Identification of regions protected upon binding to interaction partners

  • Mapping of conformational changes during functional cycles

When studying Y. pestis specifically, researchers should consider examining interactions between fusA and species-specific regulatory factors that might modulate translation during infection processes or stress responses. The Y. pestis type III secretion system (T3SS) represents a crucial virulence mechanism that "enables Y. pestis to inject proteins into macrophages and other immune cells" , and potential cross-regulation between translation machinery and virulence factor expression warrants investigation.

How can researchers assess the impact of fusA mutations on Y. pestis virulence?

Evaluating how fusA mutations affect Y. pestis virulence requires a multi-tiered experimental approach:

• Site-directed mutagenesis strategies:

  • Target conserved residues in GTP-binding motifs

  • Modify domain interface residues that affect interdomain communication

  • Create mutations corresponding to known antibiotic resistance phenotypes

• In vitro assays:

  • Purified protein studies to assess effects on GTPase activity

  • Reconstituted translation systems to measure effects on protein synthesis rates

  • Ribosome binding and translocation efficiency measurements

• Cellular studies:

  • Growth rate analysis under conditions relevant to host environments

  • Macrophage infection assays to assess intracellular survival

  • Expression analysis of key virulence factors like the F1 capsular antigen, which "is one of the major virulence factors of the bacterium"

• Animal model studies (with appropriate biosafety considerations):

  • Mouse models of plague infection

  • Bacterial burden quantification in tissues

  • Survival analysis following controlled infection

Given that Y. pestis is classified as a select agent and potential bioweapon , researchers might consider using attenuated strains or closely related species (Y. pseudotuberculosis) carrying equivalent fusA mutations for initial studies.

When interpreting results, it's important to recognize that fusA mutations may have pleiotropic effects since protein synthesis impacts virtually all cellular functions. Therefore, careful analysis is needed to distinguish direct effects from indirect consequences of altered translation efficiency.

What comparative analyses can reveal evolutionary insights about Y. pestis fusA?

Comparative analyses of fusA across Yersinia species and related bacteria provide valuable evolutionary insights:

• Sequence analysis:

  • Multiple sequence alignment of fusA genes from diverse bacterial species

  • Identification of conserved motifs versus variable regions

  • Calculation of selection pressure (dN/dS ratios) to identify constrained functional domains

• Structural comparison:

  • Homology modeling of Y. pestis fusA based on crystal structures from other bacteria

  • Mapping of sequence conservation onto structural models

  • Identification of species-specific structural features

• Comparative genomics:

  • Analysis of genomic context around fusA locus across Yersinia species

  • Identification of potential regulatory elements

  • Assessment of fusA copy number and potential paralogs

The evolutionary relationship between Y. pestis and Y. pseudotuberculosis is particularly informative, as "Y. pestis is thought to be descended from Y. pseudotuberculosis, DNA studies have found that the two are 83% similar" . Comparative analysis of fusA between these species may reveal adaptations specific to the plague lifestyle as opposed to the enteric pathogen lifestyle of Y. pseudotuberculosis.

Such evolutionary insights can guide functional studies by highlighting regions of fusA likely to be involved in Y. pestis-specific functions or adaptations to its unique lifecycle spanning mammalian hosts and flea vectors.

How should researchers design experiments to study fusA function in Y. pestis pathogenesis?

Designing robust experiments to investigate fusA function in Y. pestis pathogenesis requires careful consideration of genetic manipulation strategies, experimental controls, and relevant environmental conditions:

• Genetic manipulation approaches:

  • Conditional expression systems (since fusA is essential)

  • CRISPR interference (CRISPRi) for partial knockdown

  • Complementation with wild-type or mutant variants

  • Domain swapping with fusA from related species

• Experimental design matrix:

• Environmental variables to consider:

  • Temperature shifts mimicking host transitions (28°C for flea, 37°C for mammal)

  • Nutrient limitation resembling host environments

  • pH variations reflective of phagosomal conditions

  • Iron restriction, a key aspect of host-pathogen interaction

The experimental design should incorporate measurements of both molecular phenotypes (e.g., protein synthesis rates, virulence factor expression) and virulence-related phenotypes (e.g., host cell invasion, resistance to immune defenses). Particular attention should be paid to translation of virulence factors like the F1 antigen, which is "one of the major virulence factors of the bacterium" and crucial for Y. pestis pathogenicity.

What controls are essential when working with recombinant Y. pestis fusA?

Implementing appropriate controls is crucial for ensuring the validity and reproducibility of experiments involving recombinant Y. pestis fusA:

• Protein quality controls:

  • Wild-type E. coli fusA as a positive control for functional assays

  • Heat-denatured fusA as a negative control

  • Size exclusion chromatography standards to verify oligomeric state

  • Circular dichroism spectra comparison with well-characterized bacterial fusA proteins

• Expression system controls:

  • Empty vector transformants to control for host cell effects

  • Non-induced cultures to establish baseline expression

  • Alternative tags/fusion partners to distinguish tag effects from protein effects

• Functional assay controls:

  • Known fusA inhibitors (e.g., fusidic acid) as positive controls for inhibition

  • No-ribosome controls in GTPase assays to establish intrinsic activity

  • No-GTP controls to measure background phosphate levels

Critical control experiments table:

For purification quality assessment, researchers should employ approaches similar to those used for other Y. pestis proteins, where "using FPLC gel filtration chromatography and capillary electrophoresis, [researchers] have demonstrated that rF1 antigen exists as a multimer of high molecular mass" . This multi-method verification ensures that the recombinant protein maintains its native structural characteristics.

How can researchers address potential data contradictions in fusA functional studies?

When encountering contradictory results in fusA functional studies, researchers should implement systematic troubleshooting and validation approaches:

• Sources of experimental variability:

  • Protein preparation heterogeneity (verify by dynamic light scattering)

  • Buffer composition effects (test multiple buffer systems)

  • Instrument calibration issues (include standard curves)

  • Batch-to-batch variation in reagents

• Reconciliation strategies:

  • Employ multiple independent techniques to measure the same parameter

  • Vary experimental conditions systematically to identify condition-dependent effects

  • Use different expression systems to rule out host-specific artifacts

  • Increase biological and technical replicates to enhance statistical power

• Common contradictions and resolutions:

It's important to consider that fusA, like many translation factors, likely exists in multiple conformational states depending on its interaction with ribosomes, nucleotides, and other factors. This conformational flexibility can lead to apparently contradictory results when measured under different conditions, particularly when comparing in vitro and in vivo studies.

What are the latest findings on fusA's role in Y. pestis antibiotic resistance?

Recent research has illuminated important connections between fusA mutations and antibiotic resistance in Y. pestis:

• Fusidic acid resistance:

  • Fusidic acid targets EF-G (fusA) by stabilizing it on the ribosome

  • Specific mutations in domains I and III confer resistance

  • These mutations typically come with fitness costs

• Cross-resistance phenomena:

  • Some fusA mutations affect susceptibility to multiple antibiotic classes

  • Altered translation kinetics can influence sensitivity to translation-targeting antibiotics

  • Ribosome protection mechanisms may be enhanced by certain fusA variants

• Clinical relevance:

  • Natural resistant strains of Y. pestis have been identified, raising concerns about additional resistance emergence

  • "The threat of antibiotic resistance in the emergence of the two resistant natural stains of Y. pestis may become a real problem in the future if other antibiotics or alternative treatments are not discovered"

  • Surveillance for fusA mutations in clinical and environmental isolates is ongoing

Understanding fusA-mediated resistance mechanisms is particularly important given Y. pestis's classification as a re-emerging disease and potential bioterrorism agent. The emergence of antibiotic-resistant strains would significantly complicate treatment options during outbreaks, making this an area of considerable public health importance.

How is CRISPR-Cas9 being applied to study fusA function in Y. pestis?

CRISPR-Cas9 technologies are revolutionizing studies of essential genes like fusA in bacterial pathogens:

• CRISPRi approaches:

  • dCas9-based repression allows titration of fusA expression levels

  • Enables study of partial loss-of-function without lethality

  • Permits temporal control of gene expression through inducible systems

• Precise genome editing:

  • Introduction of point mutations to study specific functional residues

  • Creation of domain swaps between Y. pestis and other bacterial fusA genes

  • Addition of tags for localization studies without disrupting function

• High-throughput mutagenesis:

  • CRISPR-based scanning mutagenesis to identify critical regions

  • Creation of mutant libraries for selection experiments

  • Multiplexed editing to study epistatic interactions with other translation factors

CRISPRi experimental design table:

For Y. pestis specifically, biosafety considerations may limit some applications, but CRISPR-based approaches in attenuated strains provide valuable insights that can be extrapolated to virulent strains. Combining CRISPR technologies with proteomics analysis, similar to the "comprehensive and comparative proteomics analysis of Y. pestis strain KIM" , could reveal how fusA abundance affects the broader proteome and virulence factor expression.

What are the emerging approaches for targeting fusA in potential therapeutics?

Given the essential nature of fusA for bacterial survival and its role in antibiotic resistance, several approaches are being explored for targeting this protein in Y. pestis therapeutics:

• Structure-based drug design:

  • Virtual screening against fusA GTP-binding pocket

  • Fragment-based approaches to identify novel binding scaffolds

  • Development of allosteric inhibitors targeting Y. pestis-specific conformations

• Natural product exploration:

  • Screening of microbial extracts for fusA inhibitors

  • Modification of existing translation inhibitors for improved specificity

  • Development of fusidic acid derivatives with enhanced activity against Y. pestis

• Peptide-based inhibitors:

  • Design of peptides that mimic fusA interaction interfaces

  • Cell-penetrating peptides targeting fusA-ribosome interactions

  • Stapled peptides for improved stability and cellular uptake

• Therapeutic potential:

  • Novel therapeutic approaches are essential as "the threat of antibiotic resistance in the emergence of the two resistant natural stains of Y. pestis may become a real problem in the future if other antibiotics or alternative treatments are not discovered"

  • Targeting essential translation factors represents a viable strategy for developing new anti-plague treatments

  • Combination therapies targeting multiple steps in translation may reduce resistance development

Development of new therapeutics targeting Y. pestis is particularly important given its classification as a re-emerging disease and potential bioweapon. As noted, "exercises in bioterrorism awareness and preparedness should be made available to the general public" , and having effective treatments available is a crucial component of preparedness.